Oncology
Multiple Myeloma
Expert Perspectives in Multiple Myeloma to Cover Key Topics in Multiple Myeloma Treatment
Overview
Expert Perspectives delivers health care providers with insights from key thought leaders on the latest advancements and current practices in medicine, in a concise and timely format. Expert Perspectives in Multiple Myeloma will feature community-selected experts and topics that we hope you will find of value in your clinical practice.
VIEW THE TOPICS
Expert Roundtables
- Durability of Response With Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma
- Minimal Residual Disease Testing for Tailored Treatment in Multiple Myeloma
- Newer Options in the Management of Triple-Class Refractory Multiple Myeloma
- The Emerging Competitive Landscape in Relapsed/Refractory Multiple Myeloma
Clinical Topic Updates
- Current and Future Roles of Autologous Stem Cell Transplantation in Multiple Myeloma
- Management and Mitigation Strategies for Late-Onset Immune Effector Cell–Related Neurotoxicity
- Multiple Myeloma: High-Risk, Ultra High-Risk, and Extramedullary Disease in Focus
- Newer Treatments and Sequencing Questions in Relapsed/Refractory Multiple Myeloma
Patient Care Perspectives
- Addressing Individual Patient Needs in the Shifting Multiple Myeloma Paradigm
- Bridging Therapy Prior to Chimeric Antigen Receptor T-Cell Therapy in Patients With Multiple Myeloma
- Comorbidities and Candidacy for Chimeric Antigen Receptor T-Cell Therapy vs Autologous Stem Cell Transplantation
- Discussing the Journey: Educating and Preparing Patients for Chimeric Antigen Receptor T-Cell Therapy
Explore More in Multiple Myeloma
Multiple Myeloma
